Gordon Ruan
Impact in
-
- Histiocytic Disorders and Treatments
-
- Tumors and Oncological Cases
Papers in
- Physiology 17
- Histiocytic Disorders and Treatments 15
- Oncology 11
- Viral-associated cancers and disorders 6
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Jithma P. Abeykoon (20 shared papers)Ronald S. Go (22 shared papers)Gaurav Goyal (17 shared papers)Thomas E. Witzig (8 shared papers)Mithun Vinod Shah (16 shared papers)Jason R. Young (11 shared papers)Aishwarya Ravindran (14 shared papers)Karen L. Rech (14 shared papers)
- Journals
- Blood (8 papers)Journal of Clinical Oncology (3 papers)Blood Cancer Journal (2 papers)American Journal of Hematology (2 papers)The Oncologist (2 papers)
- Partner nations
- United StatesChinaPuerto Rico
In The Last Decade
Gordon Ruan
29 papers receiving 240 citations
Peers
Comparison fields: 5 of 53
- Physiology 144
- Pathology and Forensic Medicine 38
- Infectious Diseases 40
- Hematology 23
- Oncology 45
Countries citing papers authored by Gordon Ruan
This map shows the geographic impact of Gordon Ruan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Ruan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Ruan more than expected).
Fields of papers citing papers by Gordon Ruan
This network shows the impact of papers produced by Gordon Ruan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Ruan. The network helps show where Gordon Ruan may publish in the future.
Co-authors
The 25 scholars most cited alongside Gordon Ruan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 33 | |
| 2 | 2020 | 25 | |
| 3 | 2023 | 25 | |
| 4 | 2020 | 24 | |
| 5 | 2023 | 15 | |
| 6 | 2020 | 14 | |
| 7 | 2021 | 14 | |
| 8 | 2023 | 11 | |
| 9 | 2024 | 10 | |
| 10 | 2021 | 10 | |
| 11 | 2020 | 10 | |
| 12 | 2021 | 7 | |
| 13 | 2023 | 7 | |
| 14 | 2019 | 6 | |
| 15 | 2025 | 4 | |
| 16 | 2021 | 4 | |
| 17 | 2018 | 4 | |
| 18 | 2025 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2021 | 3 |
About Gordon Ruan
Gordon Ruan is a scholar working on Physiology, Oncology, Hematology, Molecular Biology and Surgery, having authored 35 papers that have together received 244 indexed citations. Recurring topics across this work include Histiocytic Disorders and Treatments (15 papers), Viral-associated cancers and disorders (6 papers), Chronic Myeloid Leukemia Treatments (4 papers), Magnesium in Health and Disease (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Tumors and Oncological Cases (3 papers), Acute Myeloid Leukemia Research (3 papers) and Mast cells and histamine (3 papers). The work is most often cited by research in Physiology (144 citations), Pathology and Forensic Medicine (38 citations), Infectious Diseases (40 citations), Hematology (23 citations) and Oncology (45 citations). Gordon Ruan has collaborated with scholars based in United States, China and Puerto Rico. Frequent co-authors include Jithma P. Abeykoon, Ronald S. Go, Gaurav Goyal, Thomas E. Witzig, Mithun Vinod Shah, Jason R. Young, Aishwarya Ravindran, Karen L. Rech, N. Nora Bennani and Matthew J. Koster. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Cancer Journal, American Journal of Hematology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.